AFC-HD AMS Life Science Co.,Ltd. Logo

AFC-HD AMS Life Science Co.,Ltd.

An OEM of health foods, supplements, and cosmetics, managing the full value chain from R&D to sales.

2927 | T

Overview

Corporate Details

ISIN(s):
JP3124700000
LEI:
Country:
Japan
Address:
静岡市駿河区豊田3丁目6番36号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer (OEM) specializing in health foods, dietary supplements, and cosmetics. Functioning as a holding company, it oversees a group of subsidiaries that manage the entire product value chain, from research and development to manufacturing and sales. The group's activities include direct mail order and wholesale distribution, the development and production of health-related media, and the manufacture of traditional Kampo medicines. The company leverages its integrated structure, including a dedicated R&D laboratory for product innovation and a GMP-certified manufacturing facility, to deliver a comprehensive range of quality products to its diverse customer base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-15 08:30
Registration Form
有価証券届出書(組込方式)
Japanese 260.6 KB
2025-04-14 08:33
Regulatory News Service
確認書
Japanese 8.9 KB
2025-04-14 08:32
Interim Report
半期報告書-第45期(2024/09/01-2025/08/31)
Japanese 271.0 KB
2025-02-07 02:18
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.9 KB
2024-11-28 07:36
Post-Annual General Meeting Information
臨時報告書
Japanese 28.8 KB
2024-11-27 07:34
Governance Information
内部統制報告書-第44期(2023/09/01-2024/08/31)
Japanese 24.0 KB
2024-11-27 07:33
Registration Form
確認書
Japanese 8.9 KB
2024-11-27 07:32
Registration Form
有価証券報告書-第44期(2023/09/01-2024/08/31)
Japanese 1.2 MB
2024-11-21 03:12
Regulatory News Service
臨時報告書
Japanese 24.5 KB
2024-07-16 08:02
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-07-16 08:02
Quarterly Report
四半期報告書-第44期第3四半期(2024/03/01-2024/05/31)
Japanese 211.7 KB
2024-04-15 08:08
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-04-15 08:07
Quarterly Report
四半期報告書-第44期第2四半期(2023/12/01-2024/02/29)
Japanese 268.2 KB
2024-01-15 05:58
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-01-15 05:57
Quarterly Report
四半期報告書-第44期第1四半期(2023/09/01-2023/11/30)
Japanese 214.8 KB

Automate Your Workflow. Get a real-time feed of all AFC-HD AMS Life Science Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AFC-HD AMS Life Science Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AFC-HD AMS Life Science Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea 291650
Aptevo Therapeutics Inc. Logo
Developing multi-specific antibody immunotherapies for hematologic and solid tumor cancers.
United States of America APVO
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America ACLX

Talk to a Data Expert

Have a question? We'll get back to you promptly.